Abstract-Urethane is a widely used anesthetic and yohimbine is a well-known a2 adrenergic antagonist. In fasted Wistar rats urethane at an anesthetic dose (1.25 g/kg, i.p.) caused an increase in plasma glucose, while pentobarbital at an anes thetic dose (40 mg/kg, i.p.) did not. Urethane caused no change in plasma glucose
Urethane is a widely used anesthetic agenl in animal experimentation, although it iE known to decrease the contractile responsE of vascular smooth muscle to noradrenaline or sympathomimetic agents in a specific manner (1) (2) (3) (4) (5) (6) . On the other hand, it has been known for a long time that urethane-anesthetized animals have abnormally high blood glucose levels (7) . Reinert showed that urethane induced hyperglycemia might be a conse quence of hypothalamic or general limbic ac tivation, resulting in an increased sympathetic discharge (8) . It is well-known that catechol amines regulate blood glucose, and it was reported that postsynaptic a2-receptors regu lated insulin release (9) (10) (11) (12) .
The present paper deals with the mechanisms of the hyperglycemic action of urethane. because for non-anesthetized animals, blood sampling was found to be a stressor that caused increases in plasma levels of glucose and catecholamines. As shown in Fig. 3 , yohimbine (10 mg/kg, p.o.) caused an increase in plasma nor adrenaline (norAdr) but almost no change in plasma glucose and adrenaline (Adr) in pentobarbital anesthetized rats, whereas it potentiated the urethane-induced elevation in plasma norAdr level, but partially inhibited the urethane-induced increases in plasma Adr and glucose.
4. Effect of urethane and yohimbine on plasma insulin level: As shown in Table 2 , urethane and yohimbine tended to cause increase in plasma insulin level, and pre treatment with yohimbine potentiated the urethane-induced increment.
Discussion field, we must be careful in explaining the effects of some drugs which may be exerted through the autonomic nervous system (1-6).
Yohimbine completely abolished and phen tolamine partially reduced urethane-induced hyperglycemia. Yohimbine and phentolamine did not cause a decrease in the basal glucose level.
I n pentobarbital-anesthetized rats, yohimbine caused an increase of plasma nor Adr but not of Adr. The increase of plasma norAdr seemed to reflect the release of nor Adr from sympathetic nerve terminals as a consequence of the blocking effect of yohimbine on presynaptic a2-receptor. Yohimbine partially inhibited the urethane induced elevation of plasma Adr but poten tiated that of norAdr. In the present study, that activity of norAdr was less than one fourth that of Adr in increasing plasma glucose (data were not shown). These results suggest that yohimbine may inhibit adrenaline release from the adrenal medulla as a consequence of the blocking action on the central nervous system.
Yohimbine at a dose of 10 mg/kg partially (about 60%) reduced exogenous Adr (0.2 mg/kg, s.c.)-induced hyperglycemia 30 min after administration of Adr (data were not shown). It is known that plasma Adr causes an increase in blood glucose as a result of stimulation of hepatic gluconeogenesis and of inhibition of insulin release from the islets of Langerhans (9) (10) (11) (12) . The increase in plasma insulin level following urethane adminis tration may be due to the elevation of plasma glucose.
Yohimbine tended to cause an increase in plasma insulin level, and pretreat ment with yohimbine potentiated the urethane-induced elevation. It is known that glucagon secretion was stimulated by adren ergic 8-receptor stimulants (17). However, in contrast to the role of insulin, the role of glucagon in the direct glycemic action of epinephrine has been less clear (17). There fore, it is suggested that yohimbine may inhibit the urethane-induced hyperglycemia via its inhibitory action on Adr secretion and also through its blocking action on peripheral a-receptors for Adr. Chlorpromazine causes an increase in plasma glucose due to its a adrenoceptor stimulating action and this is prevented by yohimbine (18). Thus, the mechanism of hyperglycemic effect of ure thane maybe similar to that of chlorpromazine. Although it has long been appreciated that catecholamines regulate not only glucose but also lipid, ketone and protein metabolism (17), the mechanism of catecholamine regu lation of such metabolisms are less clear and remain to be studied. Furthermore, the central effects of yohimbine under urethane-induced hyperglycemia still need to be clarified.
